Principal Research Scientist I
AbbVie Deutschland GmbH & Co. KG
Ludwigshafen, Rheinland-Pfalz, Germany
Mirko Koziolek is a Principal Research Scientist I in NCE Formulation Sciences at AbbVie Germany. He received his PhD in Biopharmacy and Pharmaceutical Technology from the University of Greifswald, Germany, in 2014 under the supervision of Prof. Werner Weitschies. Following his doctorate, Mirko spent 12 months in the group of Prof. Christopher Porter at the Monash Institute of Pharmaceutical Sciences in Melbourne, Australia. In 2016, Mirko returned to Greifswald and continued his research on the in vitro and in vivo characterization of drug release from oral dosage forms. This work included the design and optimization of biorelevant in vitro tools such as the GastroDuo as well as the application of different in vivo techniques such as MRI or telemetric capsules to study GI physiology and the in vivo behavior of oral formulations in humans. In October 2019, Mirko joined AbbVie in Ludwigshafen, Germany, where he is responsible for biopharmaceutical support of drug product development. Mirko is author/co-author of 50+ peer-reviewed publications and is a regular reviewer for various journals in the field of Pharmaceutical Sciences. In the European COST action on “Understanding Gastrointestinal Absorption Processes (UNGAP)”, he served as co-lead of the working group “Food-drug interface”.
Disclosure information not submitted.
Tuesday, October 18, 2022
9:00 AM – 9:30 AM ET